🌐 WorldLive
Accueil🇬🇧 Royaume-UniÉconomie

Neuland Laboratories Plans Commercial Peptide Manufacturing Facility Opening in Summer 2026

Neuland Laboratories Plans Commercial Peptide Manufacturing Facility Opening in Summer 2026

Neuland Laboratories Ltd. plans to open a commercial-scale peptide manufacturing facility in summer 2026 at its 17-acre Bonthapally campus in Hyderabad, India. The expansion aims...The post Neuland Laboratories Plans Commercial Peptide Manufacturing Facility Opening in Summer 2026 appeared first on PharmaSource.